JP2010510218A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510218A5
JP2010510218A5 JP2009537218A JP2009537218A JP2010510218A5 JP 2010510218 A5 JP2010510218 A5 JP 2010510218A5 JP 2009537218 A JP2009537218 A JP 2009537218A JP 2009537218 A JP2009537218 A JP 2009537218A JP 2010510218 A5 JP2010510218 A5 JP 2010510218A5
Authority
JP
Japan
Prior art keywords
tissue
mammal
composition
administration
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009537218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510218A (ja
JP5646851B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/024051 external-priority patent/WO2008063555A2/en
Publication of JP2010510218A publication Critical patent/JP2010510218A/ja
Publication of JP2010510218A5 publication Critical patent/JP2010510218A5/ja
Application granted granted Critical
Publication of JP5646851B2 publication Critical patent/JP5646851B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009537218A 2006-11-17 2007-11-16 エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法 Active JP5646851B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85972406P 2006-11-17 2006-11-17
US60/859,724 2006-11-17
PCT/US2007/024051 WO2008063555A2 (en) 2006-11-17 2007-11-16 Methods of enhancing immune response using electroporation-assisted vaccination and boosting

Publications (3)

Publication Number Publication Date
JP2010510218A JP2010510218A (ja) 2010-04-02
JP2010510218A5 true JP2010510218A5 (https=) 2010-11-25
JP5646851B2 JP5646851B2 (ja) 2014-12-24

Family

ID=39430332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009537218A Active JP5646851B2 (ja) 2006-11-17 2007-11-16 エレクトロポレーション支援ワクチン投与及び追加投与を用いた免疫応答の増強方法

Country Status (8)

Country Link
US (1) US20100285040A1 (https=)
EP (1) EP2091558B1 (https=)
JP (1) JP5646851B2 (https=)
KR (1) KR20090080941A (https=)
CN (1) CN101522211A (https=)
AU (1) AU2007322075B2 (https=)
CA (1) CA2668649A1 (https=)
WO (1) WO2008063555A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010148440A1 (en) 2009-06-24 2010-12-29 International Scientific Pty Ltd An apparatus and method of treatment utilizing a varying electromagnetic energisation profile
KR101723605B1 (ko) * 2014-10-21 2017-04-07 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
US10233419B2 (en) 2016-06-30 2019-03-19 Zymergen Inc. Apparatuses and methods for electroporation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US118956A (en) * 1871-09-12 Improvement in apparatus for the manufacture of extracts from hemlock and other
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US6009345A (en) 1992-08-17 1999-12-28 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
US5439440A (en) 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
JP2001520537A (ja) 1997-04-03 2001-10-30 エレクトロフェクト・アクティーゼルスカブ 医薬品と核酸の骨格筋への導入方法
TW368420B (en) 1997-11-04 1999-09-01 Genetronics Inc Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
US6972013B1 (en) 1998-07-13 2005-12-06 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
WO2000045823A1 (en) * 1999-02-08 2000-08-10 Chiron Corporation Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
US7171264B1 (en) * 1999-05-10 2007-01-30 Genetronics, Inc. Intradermal delivery of active agents by needle-free injection and electroporation
GB9922361D0 (en) * 1999-09-21 1999-11-24 Isis Innovation Generating an immune response to an antigen
JP2004528012A (ja) * 2000-11-01 2004-09-16 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ 改善された免疫応答を誘導し得る発現ベクターおよびこのベクターの使用方法
WO2002072781A2 (en) 2001-03-13 2002-09-19 University Of South Florida Electromanipulation device and method
CN1607941A (zh) * 2001-11-19 2005-04-20 贝克顿迪肯森公司 粒状药物组合物
AU2002360648B2 (en) * 2001-12-14 2009-01-08 Genetronics, Inc. Methods for particle-assisted polynucleotide immunization using a pulsed electric field
US20060035853A1 (en) * 2004-01-07 2006-02-16 Biomedical Research Models, Inc. Methods for tailoring the immune response to an antigen or immunogen
CA3063263C (en) 2006-02-11 2024-01-16 Genetronics, Inc. Device and method for single-needle in vivo electroporation

Similar Documents

Publication Publication Date Title
Bal et al. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
WO2015024667A8 (en) Method for increasing expression of rna-encoded proteins
RU2016106134A (ru) Иммуногенные противовоспалительные композиции
MX2021001762A (es) Metodo y composicion para estimular la respuesta inmunitaria.
JP2012041342A5 (https=)
WO2012027379A3 (en) Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
Shakya et al. Microneedle-mediated allergen-specific immunotherapy for the treatment of airway allergy in mice
JP2012529488A5 (https=)
ME02662B (me) Niskofrekventna terapija glatiramer acetatom
NZ630790A (en) Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
Yan et al. Enhancement of Ag85B DNA vaccine immunogenicity against tuberculosis by dissolving microneedles in mice
FI3501534T3 (fi) Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia
JP2016539946A5 (https=)
WO2009089535A3 (en) Polypeptide vaccine and vaccination strategy against mycobacterium
CN107427567A (zh) 检查点抑制剂和疫苗组合物及其用于免疫疗法的用途
JP2015520196A5 (https=)
JP2016520089A5 (https=)
JP2015533376A5 (https=)
JP2014513722A5 (https=)
CN104168912A (zh) 促进剂-dna组合疫苗
JP2016539105A5 (https=)
WO2015140175A9 (en) A medicament for use in a method of inducing or extending a cellular cytotoxic immune response
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
JP2018536002A5 (https=)
RU2015116264A (ru) Композиции и способы лечения сердечной недостаточности у пациентов с диабетом